1. Adam, E., Nasz, I. and Lengyel, A. (1995) Antigenic homogenicity among the adenovirus hexon types of the subgroup C. Arch. Virol. 140: 1297–1301.
2. Anderson, K. and Fennie, E. (1987) Adenovirus early region la modulation of interferon antiviral activity. J. Virol. 61: 787–795.
3. Anderson, W. F. (1992) Human gene therapy. Science 256: 808–813.
4. Barr, D., Tubb, J., Ferguson, D., Scaria, A., Lieber, A., Wilson, C., Perkins, J. and Kay, M. A. (1995) Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2: 151–155.
5. Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong,.J.S., Horwitz, M. S., Crowell, R. L. and Finberg R.W. (1997) Isolation of a common receptor for coxsackie B virus and adenovirus 2 and 5. Science 275: 1320–1323.